Buchang Pharma subsidiary establishes new medical technology company
Shandong Buchang Pharmaceuticals Co., Ltd. announced that its controlling subsidiary, Buchang Golden Key Pharmaceutical Technology Co., Ltd., plans to establish Zhuhai Daqianpo Buchang Medical Technology Co., Ltd. The new company will have a registered capital of 1,000,000 yuan.
Buchang Golden Key will invest 510,000 yuan for a 51% stake. The remaining 49% will be held by Yin Weiqun, executive director of Guangzhou Meizihe Cosmetics Co., Ltd.
Located in Zhuhai City, Guangdong Province, the new entity will focus on cosmetics wholesale, sales of medical devices (Class I and II), daily necessities, personal hygiene products, and disinfectant sales. It will also provide supply chain management, consulting, and sales agency services.
The investment of 510,000 yuan will be made in cash from Buchang Golden Key's own funds. This transaction was approved by the board of directors on December 10, 2025, and does not require shareholder approval. The company expects the investment to positively impact its long-term operating capability and competitiveness.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shandong Buchang Pharmaceuticals publishes news
Free account required • Unsubscribe anytime